REFERENCES
1 Isoda R, Yamane H, Nezuo S, et al. Successful palliation for an aged patient with primary pericardial mesothelioma. World J Surg Oncol, 2015, 13: 273.
2 Matsuyama S, Imazuru T, Uchiyama M, Ota H, Iida M, Shimokawa T. Primary malignant pericardial mesothelioma presenting with cardiac tamponade. Int J Surg Case Rep. 2020;73:253-256.
3 Mensi C, Giacomini S, Sieno C, et al. Pericardial mesothelioma and asbestos exposure. Int J Hyg Environ Health, 2011, 214: 276-279.
4 Fujita K, Hata M, Sezai A, et al. Three-year survival after surgery for primary malignant pericardial mesothelioma: report of a case. Surg Today, 2014, 44: 948-951.
5 Adler Y, Charron P, Imazio M,et al. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases: the task force for the diagnosis and management of pericardial diseases of the European Society of Cardiology (ESC). Eur Heart J 2015;36:2921–2964.
6 Peebles CR, Shambrook JS, Harden SP. Pericardial disease–anatomy and function.
Br J Radiol 2011;84 Spec No 3(Spec Iss 3):S324–S337.
7 Pennell DJ, Sechtem UP, Higgins CB, Manning WJ, Pohost GM, Rademakers FE,
van Rossum AC, Shaw LJ, Yucel EK. Clinical indications for cardiovascular magnetic resonance (CMR): consensus panel report. Eur Heart J 2004;25:1940–1965
8 Suman S, Schofield P, Large S. Primary pericardial mesothelioma presenting as
pericardial constriction: a case report. Heart 2004;90:e4.
9 McGehee E, Gerber DE, Reisch J, Dowell JE. Treatment and outcomes of primary
pericardial mesothelioma: a contemporary review of 103 published cases. Clin Lung
Cancer. 2019;20(2): e152-e157.
10 Xing Rongge,Zhang Xin,Zhang Xiaoling,et al. Clinical pathological features of pleural malignant mesothelioma and related antibodies [J]. Hebei Medical,2010,32( 8): 934-936.
11 CEN Yulan. Clinical pathological analysis of 20 cases of malignant mesothelioma[J]. Clinical Review, 2008, 23( 1): 43-44.
12 Kong Lingyun, Wang Jingrui, Sun Lanlan, Zhu Weiwei, et al. pathological and prognostic summary analysis of primary malignant pericardial mesothelioma in Chinese mainland 35 years[J].Chinese Journal of Circulation,2017,32(10):1005-1009.
13 Tang Qile,Xu Li,Xu Wenjuan,et al. Clinicopathological analysis of pericardial primary malignant mesothelioma[J]. Journal of Clinical and Experimental Pathology,2001,17(5): 400-403.
14 HUSAIN A N, COLBY T V, ORDÓÑEZ N G, et al.Guidelines for pathologic diagnosis of malignant mesothe⁃lioma 2017 update of the consensus statement from the international mesothelioma interest group[J]. Arch Pathol Lab Med, 2018, 142(1): 89-108. [15] JOVY, CIBAS E S, PINKUS G
15 Apicella G, Boulemden A, Citarella A, et al.Surgical treatment of a primary malignant pericardial mesothelioma: case report. Acta Chir Belg. 2022 Feb;122(1):48-50.
16 Fujita K, Hata M, Sezai A, et al. Three-year survival after surgery for primary malignant pericardial mesothelioma: report of a case. Surg Today, 2014, 44: 948-951.
17 Agarwal V,Agarwal S,Srivastava AK,et al. Primary cardiac tumors: surgical experience and follow up. Indian Heart J,2003,55: 632-636.